Related Experiment Video

Updated: Mar 3, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K

Pediatric Uveitis in a Well-Defined Population: Improved Outcomes with Immunosuppressive Therapy

David S Curragh1, Marie O'Neill1, Clara E McAvoy1

  • 1a Department of Ophthalmology , Royal Victoria Hospital , Belfast, UK.

Ocular Immunology and Inflammation
|April 28, 2017
PubMed

Insights

This study on pediatric uveitis in Northern Ireland found a mixed etiology, with juvenile idiopathic arthritis-associated uveitis being most common. Close monitoring helped most young patients maintain good vision.

Area of Science:

  • Ophthalmology
  • Pediatric Rheumatology

Background:

  • Pediatric uveitis is a significant cause of vision loss in children.
  • Understanding the epidemiology and outcomes is crucial for effective management.

Purpose of the Study:

  • To determine the incidence, causes, visual results, and complications of pediatric uveitis.
  • To analyze data from a dedicated multidisciplinary uveitis clinic in Northern Ireland.

Main Methods:

  • Retrospective chart review of pediatric uveitis patients (onset <16 years) from 2011-2015.
  • Data collected included demographics, disease characteristics, treatments, visual acuity, and complications.

Main Results:

  • 94 pediatric patients were included. Juvenile Idiopathic Arthritis-associated uveitis (JIAU) was the leading cause (48%).
  • Complications were present in 37% at presentation and 65% by final visit. Systemic treatments were used in 65% of cases.
  • 92% of eyes achieved ≥ 6/12 visual acuity at a 5-year follow-up.

Conclusions:

  • Pediatric uveitis in this cohort has a mixed etiology, with JIAU being predominant.
  • Effective management and close monitoring allow most children to retain good vision.
Abstract

Keywords:
InflammationJIANorthern Irelandpediatricuveitis

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
614
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K